Matt Farrer
Cited by
Cited by
α-Synuclein locus triplication causes Parkinson's disease
AB Singleton, M Farrer, J Johnson, A Singleton, S Hague, J Kachergus, ...
Science 302 (5646), 841-841, 2003
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
A Zimprich, S Biskup, P Leitner, P Lichtner, M Farrer, S Lincoln, ...
Neuron 44 (4), 601-607, 2004
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin, J Kachergus, C Roumier, V Mouroux, X Douay, ...
The Lancet 364 (9440), 1167-1169, 2004
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ...
New England Journal of Medicine 361 (17), 1651-1661, 2009
VPS35 mutations in Parkinson disease
C Vilari˝o-GŘell, C Wider, OA Ross, JC Dachsel, JM Kachergus, ...
The American Journal of Human Genetics 89 (1), 162-167, 2011
Missing pieces in the Parkinson's disease puzzle
JA Obeso, MC Rodriguez-Oroz, CG Goetz, C Marin, JH Kordower, ...
Nature medicine 16 (6), 653-661, 2010
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
Nature Reviews Genetics 7 (4), 306-318, 2006
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
M Farrer, J Kachergus, L Forno, S Lincoln, DS Wang, M Hulihan, ...
Annals of Neurology: Official Journal of the American Neurologicalá…, 2004
α-Synuclein shares physical and functional homology with 14-3-3 proteins
N Ostrerova, L Petrucelli, M Farrer, N Mehta, P Choi, J Hardy, B Wolozin
Journal of Neuroscience 19 (14), 5782-5791, 1999
A genome-wide linkage and association scan reveals novel loci for autism
LA Weiss, DE Arking
Nature 461 (7265), 802-808, 2009
Parkin protects against the toxicity associated with mutant α-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons
L Petrucelli, C O'Farrell, PJ Lockhart, M Baptista, K Kehoe, L Vink, P Choi, ...
Neuron 36 (6), 1007-1019, 2002
A genome-wide scan for common alleles affecting risk for autism
R Anney, L Klei, D Pinto, R Regan, J Conroy, TR Magalhaes, C Correia, ...
Human molecular genetics 19 (20), 4072-4082, 2010
Alpha‐synuclein p. H50Q, a novel pathogenic mutation for Parkinson's disease
S Appel‐Cresswell, C Vilarino‐Guell, M Encarnacion, H Sherman, I Yu, ...
Movement disorders 28 (6), 811-813, 2013
Lewy bodies and parkinsonism in families with parkin mutations
M Farrer, P Chan, R Chen, L Tan, S Lincoln, D Hernandez, L Forno, ...
Annals of Neurology: Official Journal of the American Neurologicalá…, 2001
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations
J Kachergus, IF Mata, M Hulihan, JP Taylor, S Lincoln, J Aasly, JM Gibson, ...
The American Journal of Human Genetics 76 (4), 672-680, 2005
High-resolution whole-genome association study of Parkinson disease
DM Maraganore, M De Andrade, TG Lesnick, KJ Strain, MJ Farrer, ...
The American Journal of Human Genetics 77 (5), 685-693, 2005
Collaborative analysis of α-synuclein gene promoter variability and Parkinson disease
DM Maraganore, M De Andrade, A Elbaz, MJ Farrer, JP Ioannidis, ...
Jama 296 (6), 661-670, 2006
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database
CM Lill, JT Roehr, MB McQueen, FK Kavvoura, S Bagade, BMM Schjeide, ...
PLoS genetics 8 (3), e1002548, 2012
LRRK2 in Parkinson's disease: protein domains and functional insights
IF Mata, WJ Wedemeyer, MJ Farrer, JP Taylor, KA Gallo
Trends in neurosciences 29 (5), 286-293, 2006
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU H÷glinger, NM Melhem, DW Dickson, P Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699-705, 2011
The system can't perform the operation now. Try again later.
Articles 1–20